112 related articles for article (PubMed ID: 1584106)
1. Immunological correlations between ontogenesis and oncogenesis: theoretical implications and suggestions for tumor immunotherapy.
Manzo G
Med Hypotheses; 1992 Mar; 37(3):166-70. PubMed ID: 1584106
[TBL] [Abstract][Full Text] [Related]
2. The cancer process as a type of immunocomplex hypersensibility involving C3b, natural killer cytotoxicity and antibody-dependent cell cytotoxicity: proposals for tumour immunotherapy and vaccine.
Manzo G
Med Hypotheses; 1998 May; 50(5):409-13. PubMed ID: 9681920
[TBL] [Abstract][Full Text] [Related]
3. Cancer genesis: stem tumour cells as an MHC-null/HSP70 - very high 'primordial self' escaping both MHC-restricted and MHC-non- restricted immunesurveillance.
Manzo G
Med Hypotheses; 2001 Jun; 56(6):724-30. PubMed ID: 11399124
[TBL] [Abstract][Full Text] [Related]
4. Non-MHC-restricted target-cell lysis by a CD4-CD8- TCR alpha beta T-cell line, as well as by TCR gamma delta T-cell lines, results from lymphokine-activated killing.
Maziarz RT; Groh V; Prendergast M; Fabbi M; Strominger JL; Burakoff SJ
Int J Cancer; 1991 Apr; 48(1):142-7. PubMed ID: 1902200
[TBL] [Abstract][Full Text] [Related]
5. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
6. Can the dual-functional capability of CIK cells be used to improve antitumor effects?
Wang X; Yu W; Li H; Yu J; Zhang X; Ren X; Cao S
Cell Immunol; 2014 Jan; 287(1):18-22. PubMed ID: 24355711
[TBL] [Abstract][Full Text] [Related]
7. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cytolytic and proliferative activities of human gamma delta and alpha beta T cells from peripheral blood against various human tumor cell lines.
Ensslin AS; Formby B
J Natl Cancer Inst; 1991 Nov; 83(21):1564-9. PubMed ID: 1683671
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
Suzuki H; Ikemoto M; Yokoyama A; Kamitani T; Yamashita N; Maruyama M; Yano S
Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
[TBL] [Abstract][Full Text] [Related]
10. Long-term culture growth of CD4-CD8- lymphocytes exhibiting elevated non-MHC-restricted cytotoxic activity.
Montesoro E; Bulgarini D; Carè A; Masciulli R; Giannella G; Mariani G; Samoggia P; Salvo G; Habetswallner D; Testa U
J Biol Regul Homeost Agents; 1991; 5(1):10-8. PubMed ID: 1715635
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules.
Chong AS; Boussy IA; Graf LH; Scuderi P
Cell Immunol; 1992 Oct; 144(1):69-79. PubMed ID: 1356634
[TBL] [Abstract][Full Text] [Related]
12. Cloned CD3+ TcR alpha/beta- Ti gamma A- peripheral blood lymphocytes compared to the Ti gamma A+ counterparts: structural differences of the gamma/delta receptor and functional heterogeneity.
Jitsukawa S; Triebel F; Faure F; Miossec C; Hercend T
Eur J Immunol; 1988 Nov; 18(11):1671-9. PubMed ID: 2849548
[TBL] [Abstract][Full Text] [Related]
13. Adoptive cellular immunotherapy of cancer.
Winter H; Fox BA
Curr Opin Mol Ther; 1999 Feb; 1(1):89-97. PubMed ID: 11249690
[No Abstract] [Full Text] [Related]
14. Human NK cells: From surface receptors to clinical applications.
Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A
Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of cancer with lymphokines and lymphokine-activated killer cells.
Yarbro JW
Semin Surg Oncol; 1991; 7(4):183-91. PubMed ID: 1925249
[TBL] [Abstract][Full Text] [Related]
16. Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis.
Fisch P; Malkovsky M; Braakman E; Sturm E; Bolhuis RL; Prieve A; Sosman JA; Lam VA; Sondel PM
J Exp Med; 1990 May; 171(5):1567-79. PubMed ID: 2185329
[TBL] [Abstract][Full Text] [Related]
17. Appearance of extrathymic early differentiated CD4-CD8- T cells with T cell receptor gamma/delta or alpha/beta after thymus grafting to nude mice: influence of thymus on extrathymic T cell differentiation.
Kenai H; Yoshikai Y; Matsuzaki G; Iwasaki A; Yuuki H; Nakamura T; Nomoto K
Cell Immunol; 1994 Jan; 153(1):79-93. PubMed ID: 8287494
[TBL] [Abstract][Full Text] [Related]
18. Cancer: a biological problem without any natural immunological solution? A unified theory, with implications for grafts, pregnancy and tumour immunoprophylaxis.
Manzo G
Med Hypotheses; 1995 Oct; 45(4):317-24. PubMed ID: 8577291
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of rat T cell subpopulations expressing T cell receptors alpha/beta and gamma/delta.
Lawetzky A; Tiefenthaler G; Kubo R; Hünig T
Eur J Immunol; 1990 Feb; 20(2):343-9. PubMed ID: 2138084
[TBL] [Abstract][Full Text] [Related]
20. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
Aramburu J; Balboa MA; Ramírez A; Silva A; Acevedo A; Sánchez-Madrid F; De Landázuri MO; López-Botet M
J Immunol; 1990 Apr; 144(8):3238-47. PubMed ID: 1691231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
